In February 2004 Lux biotechnology finalised patent filing for its novel biosensor and assay based on luminescent and fluorescent filamentous fungi
This is the second patent completed since the beginning of 2004.
Lux specialises in the development of screening technologies and optoelectronics, and these patents represent a key step in the development of the company's biosensor technology portfolio.
Lux's technologies are targeted for use in toxicology testing, high throughput screening, diagnostics and basic research.
